Grants

Since awarding our first grant in 1994, the V Foundation has funded more than $170 million in research grants. Our Scientific Advisory Committee selects grant recipients through a highly competitive process. We invest in promising people and projects.

Because of highly competitive reviews, V Foundation grant recipients invariably have excellent reputations within the scientific community.

Types of Grants

The V Foundation for Cancer Research currently awards four types of grants:

 

V Scholar Grant

The V Scholar Grant is a two-year grant of $100,000 per year. It supports young tenure-track faculty early in their cancer research careers by funding projects that are either laboratory-based fundamental research or translational research.

 

Translational Grant

The Translational Grant is a three-year grant of $200,000 per year. These grants support “bench to bedside” research, whose endpoint is often planning or initiation of a clinical trial.

 

Designated Grant

The Designated Grant supports basic or translational research at research institutions that may reach beyond our usual grant list. The size and duration of these grants vary widely depending on the initiative, but they have ranged from $50,000 to over $1 million.

 

Mission Grant

These grants are made to support projects within the mission of the V Foundation, but they are not usually for the direct support of a research project. The Mission Grant is a smaller grant type (under $100,000 per year).

Find a grant

View all types of cancer research funded by the V Foundation in 2016. To show a specific cancer type, deselect “All.” Click on a pin or scientist name to learn more about that grant.

Find a grant

Grant Process FAQ

The V Foundation for Cancer Research supports research on all types of cancer. We invite the best researchers at the National Cancer Institute’s designated cancer centers and other exceptional research institutions to apply for our V Scholar Grant and Translational Grant awards. Research proposals are reviewed and recommended for funding by our Scientific Advisory Committee, a group whose members are leaders in the cancer research field.